Controls | ICU | ||
---|---|---|---|
D1 | D4 | ||
Total Enteterobacteriaceae isolated (n = 444) | 181 | 145 | 118 |
Characteristics of CRE (n = 91) | 20 | 31 | 40 |
1. Species distribution pattern | |||
Escherichia coli | 16 | 28 | 30 |
Klebsiella sp. | 2 | 3 | 9 |
Proteus sp. | 2 | 0 | 0 |
Enterobacter sp. | 0 | 0 | 1 |
2. MIC range (mg/L) | |||
Ertapenem | 0.75-64 | 0.75-64 | 0.75-64 |
Imipenem | 0.25-64 | 0.25-64 | 0.25-64 |
Meropenem | 0.064-64 | 0.047-64 | 0.064-64 |
3. Phenotypic characterization | |||
MBL | 10 | 11 | 15 |
KPC | 0 | 0 | 2 |
Non MBL/KPC Carbapenemase | 0 | 3 | 9 |
Only ESBL and/or AmpC | 10 | 15 | 11 |
No β lactamases class | 0 | 2 | 3 |
Characteristics of CPE isolates (n = 50) | 10 | 14 | 26 |
1. Species distribution pattern | |||
Escherichia coli | 6* | 14¥ | 19$ |
Klebsiella sp. | 2* | 0 | 6 ҍ |
Proteus sp. | 2* | 0 | 0 |
Enterobacter sp. | 0 | 0 | 1# |
2. MIC range (mg/L) | |||
Ertapenem | 64-64 | 3-64 | 2-64 |
Imipenem | 64-64 | 0.38-64 | 0.38-64 |
Meropenem | 64-64 | 0.5-64 | 0.38-64 |
3. Distribution of β- lactamases | |||
TEM | 4 | 10 | 14 |
SHV | 1 | 4 | |
CTXM | 2 | 9 | 22 |
CIT | 1 | 1 | |
DHA | 2 | 3 | |
MOX | 2 | ||
NDM-1 | 10 | 12 | 17 |
KPC | 2 | ||
OXA-48 | 1 | 7 | |
OXA-181 | 2 | 8 | |
Characteristics of NON-CPE isolates (n = 41) | 10 | 17 | 14 |
1. Species distribution pattern | |||
Escherichia coli | 10 | 14 | 11 |
Klebsiella sp. | 3 | 3 | |
2. MIC range (mg/L) | |||
Ertapenem | 0.75-8 | 0.75-64 | 0.75-64 |
Imipenem | 0.25-2 | 0.25-64 | 0.25-64 |
Meropenem | 0.064-0.75 | 0.047-64 | 0.064-64 |
3. Distribution of β- lactamases | |||
TEM | 5 | 9 | 9 |
CTXM | 6 | 8 | 7 |
DHA | 1 | ||
EBC | 1 | ||
CIT | 5 | ||
No enzyme detected | 2 | 3 | 2 |